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Summary The human breast cancer cell line MCF-7 requires oestrogen to produce and promote growth of
tumours in athymic mice. In vitro, however, MCF-7 cells proliferate rapidly without supply of oestrogen
(Briand & Lykkesfeldt, 1984). Oestrogen stimulation of proliferation of MCF-7 cells can be achieved when
the cells are grown at high concentration of newborn calf serum (NCS, 10%) or oestrogen deprived foetal calf
serum (10%). The stimulation involves an abolishment of inhibitory activity present in the serum. The
oestradiol stimulated cultures grow rapidly for a much longer time period and attain a much higher cell
density than the unstimulated cultures. Oestrogen is specific for the promotion of cell proliferation and only
oestrogen receptor positive cell lines with a functional oestrogen receptor mechanism can be stimulated. We
assume that oestradiol acts directly on the cells and via the oestrogen receptor mechanism induces the
synthesis of a substance which abolishes the inhibitory activity in serum. We call this mechanism of action an
indirect stimulation of cell proliferation. A similar mechanism may exist in vivo since we find that serum from
athymic mice contains a growth inhibitory activity towards MCF-7 cells and the inhibitory effect can be
abolished by oestradiol.
Oestradiol has a growth promoting effect on
oestrogen receptor positive human breast cancer
cell lines (Lippman et al., 1976; Barnes & Sato,
1979; Allegra & Lippman, 1980; Chalbos et al.,
1982; Leung et al., 1982; Darbre et al., 1983; Page
et al., 1983; Dembinsky & Green, 1983; Natoli et
al., 1983; Soto & Sonnenschein, 1984). However,
the same cell line may be oestrogen responsive in
one laboratory whereas it is nonresponsive in
another laboratory (Butler et al., 1983; Iacobelli et
al., 1984; Katzenellenbogen et al., 1984). These
differences may be due to different growth
conditions and also divergence of the cell lines
(Natoli et al., 1983; Katzenellenbogen et al., 1984).
An understanding of the mechanism underlying the
oestrogen stimulation of cell proliferation of human
breast cancer cells may be of great importance for
the treatment of oestrogen dependent human breast
tumours. We have therefore tried to establish
culture conditions under which oestrogen
stimulation of cell proliferation can be obtained.
Recent reports in the literature suggest that serum
factors may be involved in the oestrogen
stimulation (Leung et al., 1982; Darbre et al., 1983;
Page et al., 1983; Dembinsky et al., 1983; Soto &
Sonnenschein, 1984) and high concentration of
serum may be needed to achieve sufficient serum
factor concentrations. By the use of the human
breast cancer cell line MCF-7 we have found
growth conditions with high serum concentration
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under which we can reproducibly obtain oestrogen
stimulation of cell proliferation. We have
investigated whether oestradiol is specific for the
stimulation. To determine whether the oestrogen
receptor mechanism is involved in the stimulation
of cell proliferation we have analysed several other
human breast cancer cell lines, including an anti-
oestrogen-tesistant subline of MCF-7 cells, with
respect to oestrogen and progesterone receptor
content and the number of cells obtained after
cultivation for seven days in medium with and
without oestradiol. Since oestrogen supplement is
required for the formation of tumours of MCF-7
cells in athymic mice, we have also investigated
whether MCF-7 cells grown in vitro can be
stimulated by oestradiol when grown in the
presence of athymic mouse serum.
Materials and methods
Cell culture
The human breast cancer cell lines MCF-7, T47D,
ZR-75-1 and BT-20 were kindly supplied from the
Human Cell Culture Bank, Mason Research
Institute (Rockville, MD, USA). The HBL-100 cell
line, derived from cells in normal human milk, was
a gift from the Breast Cancer Task Force Cell
Culture Bank (Worcester, MA, USA). The MCF-7
cells were propagated in growth medium with 0.5%
heat inactivated foetal calf serum (FCS) as
described previously (Briand & Lykkesfeldt, 1984)
or in serum free medium consisting of DME/F12
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(1:1) supplemented with glutamine (Sigma
Chemical Co., St Louis, MO, USA), insulin,
epidermal growth factor, transferrin and sodium
selenite (Collaborative Research, Waltham, MA,
USA) in collagen IV (Sigma Chemical Co., St
Louis, MO, USA) coated plastic flasks (Nunc,
Roskilde, Denmark) (Briand & Lykkesfeldt, 1983).
We have derived the AL-1 cell line from MCF-7
cells. A T-75 flask seeded with 3.75 x 105 cells was
shifted to medium with 1O-6M tamoxifen after one
day in growth medium. After 5 days in the presence
of tamoxifen the cell number had increased to
7 x 106, and the culture was split 1:10. Tamoxifen
treatment of the subculture continued for 21 days.
Now only two colonies ofsurviving cells were visible
in the culture flask. The cells were allowed to grow
for another 22 days in medium without tamoxifen
and after this period of time 8 colonies appeared in
the culture flask. Each colony was trypsinized and
transferred separately to new culture flasks, and
four of these colonies could be maintained in tissue
culture. After the first sub.cultivation of the isolated
colonies (sublines) the cells were maintained in
medium with 10-6M tamoxifen with a parallel
culture without tamoxifen. The sublines grown with
tamoxifen all died after 5 to 7 passages with a total
number of cell doublings between 8 to 14. One of
the sublines maintained in control medium was
transferred to tamoxifen medium after 19 passages
(subline AL-El, first passage) and have now
continued growth in 10-6M tamoxifen for 29
passages with a split ratio of 1:15 every week. The
AL subline is maintained in medium with 10-6 M
tamoxifen, and cells from passage 9 to 26 have
been used in the experiements. The other cell lines
were propagated according to the recommendations
from the Cell Culture Bank, except that the HBL-
100 cell line was adapted to growth with 0.5%
FCS.
Growth experiments
MCF-7 cells were seeded in growth medium
supplemented with 0.5% FCS, penicillin,
250IUml-1 (Leo Pharmaceuticals, Ballerup,
Denmark) and streptomycin, 25 gmml-1 (Sigma
Chemical Co., St Louis, MO, USA). One day after
plating the cells were changed to medium with
different concentrations of NCS. The different
hormones, oestradiol, progesterone, hydrocortisone
(Collaborative Research, Waltham, MA, USA) and
testosterone (Sigma Chemical Co., St Louis, MO,
USA) were dissolved in ethanol, and the final
concentration of ethanol in the cultures were 0.1%.
Control cultures received 0.1% ethanol. The cell
number was determined by cell counts in a Biirker-
Tiirck chamber after trypsinization. The cell lines
maintained at 10% FCS (BT-20, ZR-75-1 and
T47D) were grown for one week with 10% NCS
before start of the experiments to reduce the
cellular level of oestrogen compounds supplied by
the FCS. The cells were seeded with 10% NCS and
one day after plating half of the cultures received
10-8 M oestradiol.
Athymic mouse serum
Female nude mice of the inbred athymic BALB/c
strain were anesthetized with propanidid (Epontol,
Bayer Kemi A/S, Copenhagen, Denmark). The
thoracic cavity was opened and the aortic artery
was cut through. The blood was collected from the
cavity with a syringe and needle. It was left over-
night in the cold room and centrifuged at 1300g for
10min to obtain the serum. In later experiments,
blood was collected from animals that were killed
by cervical dislocation, and the results obtained
were similar.
Oestrogen andprogesterone receptor
Near confluent cultures were harvested for receptor
determination. The preparation of cytosol has been
described previously (Briand & Lykkesfeldt, 1984),
and the dextran-charcoal technique was used for
receptor determinations (EORTC Breast Co-
operative Group, 1980).
Results
The human breast cancer cell line MCF-7 is now
routinely propagated in medium supplemented with
0.5% foetal calf serum (FCS). Oestradiol does not
stimulate cell proliferation under these growth
conditions (Briand & Lykkesfeldt, 1984). If the
cells, however, are grown in the presence of 10%
newborn calf serum (NCS), addition of oestradiol
(10-8M) results in a significant increase in the
number of cells per culture flask (Figure 1). MCF-7
cells grown in low concentration of NCS (2%)
proliferate as rapidly as those cultured in 0.5%
FCS or 10% NCS+ 10-8 M oestradiol (Figure 1),
and addition of oestradiol to cultures grown in
2% NCS does not result in stimulation of cell
proliferation (Lykkesfeldt & Briand, 1985). The
logarithmic growth phase is much longer in the
cultures with low serum concentration and with
10% NCS+10-8M oestradiol, than in the cultures
grown in high NCS concentration (10%) alone
(Figure 1). Consequently the final cell density is
much higher in these cultures than in the cultures
with 10% NCS. The decreased cell proliferation
capability observed with high NCS concentrations
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Figure 1 Effect of NCS and NCS + oestradiol on
growth of MCF-7 cells. MCF-7 cells propagated in
medium with 0.5% heat inactivated foetal calf serum
(FCS) as described previously (Briand & Lykkesfeldt,
1984) were seeded in plastic T-25 flasks at a cell
density of 5 x 103 cm-2. One day after plating (day 0),
the cultures were divided into 4 groups. One group
was continued in 0.5% FCS (El), the other groups
were supplemented with 10% NCS (O), 2% NCS (A)
or 10% NCS + 10-8M oestradiol (0). The medium
was renewed 3 times weekly during the experiment.
Three cultures in each group were counted in Biirker-
Turck chamber after trypsinization at the days
indicated in the figure. The lines are drawn between
median cell number in three T-25 flasks.
growth inhibitory effect. A direct demonstration of
the presence of growth inhibitory activity in NCS
appears from the results presented in Table I.
MCF-7 cells adapted to growth in serum-free
medium are growth inhibited by addition of 10%
NCS, and this growth inhibition can be abolished
by oestradiol. Oestrogen stimulation of MCF-7 cells
grown with 10% FCS can be obtained if the serum
is treated with dextran-coated charcoal in order to
reduce the oestrogen level (Lykkesfeldt & Briand,
1985).
We tested whether other steroid hormones have a
growth promoting effect on MCF-7 cells grown in
10% NCS (Table II). Neither progesterone, nor
hydrocortisone stimulated growth. However, a high
concentration of testosterone (10-8 M) stimulated
growth whereas testosterone in low concentration
(10-10M) has no stimulatory effect.
Several cell lines have been used to investigate
whether the oestrogen receptor mechanism is
involved in growth stimulation by oestradiol. We
tested the effect of NCS and NCS+oestradiol on
MCF-7 cells and other human breast cancer cell
lines and a cell line HBL-100, derived from cells in
normal human milk. As seen in Table III, the two
oestrogen receptor negative cell lines, HBL-100 and
BT-20, do not respond to oestradiol. Of the four
oestrogen receptor positive cell lines both MCF-7
and T47D show a significant increase in cell
number when grown in the presence of oestradiol
whereas no stimulation is observed with the ZR-75-
1 cell line or the AL-l cell line. Of the oestrogen
receptor positive cell lines only MCF-7 and T47D
induce progesterone receptor synthesis during
growth with oestradiol (Table IV).
We have investigated whether oestrogen
stimulation in vivo may occur through abolition of
the effect of inhibitory activity. Table I shows the
result of an experiment in which serum from
athymic mice (AMS) is added to MCF-7 cells
grown in serum-free medium. The cells are growth-
inhibited by the supplement of AMS, and
oestradiol added simultaneously with the AMS
abolishes the inhibitory effect.
Discussion
Much controversy has existed about oestrogen
stimulation of growth of human breast cancer cell
lines in tissue culture. We believe that differences in
growth conditions as well as divergence of the cell
lines may explain the different results obtained by
different laboratories. In this paper we present
growth conditions under which we have obtained
reproducible results with oestradiol stimulation of
cell proliferation. We have analysed the mechanism
involved in this stimulation and in Table I we show
that NCS and AMS contain growth inhibitory
activity towards MCF-7 cells propagated under
serum-free conditions, and that simultaneous
addition of oestradiol abolishes the growth
inhibitory activity in serum. A similar stimulation
of cell proliferation by oestradiol of MCF-7 cells
grown in human serum has been described by Soto
and Sonnenschein (1984) and we have recently
I I
-
-32 A.E. LYKKESFELDT & P. BRIAND
Table I Effect of newborn calf serum and athymic mouse serum
with and without the addition of oestradiol on growth of MCF-7
cells adapted to serum free medium
Cell number x 10-5 +s.d.
Serum -Serum +Serum +Serum+10 8M E2
NCS, 10% 27.3+2.0 6.0+1.4 23.2+1.3
AMS, 1% 16.3+0.8 8.3+2.3 21.7+1.6
MCF-7 cells adapted to growth in serum-free medium (Briand &
Lykkesfeldt, 1983) have been used in this experiment. The cells were
plated in serum-free medium (DME/F12 supplemented with
glutamine, insulin, epidermal growth factor, transferrin and sodium
selenite) on collagen IV coated plastic flasks. Two days after plating,
the cultures were divided into 3 groups. One group continued in
serum-free medium, another group received serum, either newborn
calf serum (NCS 10%, or athymic mouse serum (AMS) 1%). The
third group received serum+oestradiol (E2). The medium was
renewed three times weekly and cell number in three T-25 flasks
determined at day 7.
Table II Effect of oestradiol, progesterone, hydrocortisone
testosterone on growth of MCF-7 cells with 10% NCS
and
Hormone addition Cell number x 10-ss.d. %
None 5.8+1.2 100
Oestradiol, 108M 37.1+5.2 640
Oestradiol, 10-10 M 15.3+0.8 264
Progesterone, 10-8 M 3.8+0.5 66
Progesterone, 1010M 3.0+0.7 52
Hydrocortisone, 10-8 M 3.3+0.2 57
Hydrocortisone, 10-10 M 2.7+0.8 47
Testosterone, 10-8 M 23.0+1.4 397
Testosterone, 10-1M 3.2+0.7 55
MCF-7 cells grown with 0.5% FCS were seeded in plastic T-25 flasks
at a cell density of 5 x I0 cn-2. Two days after plating, medium was
shifted to 10% NCS and the indicated amounts of oestradiol,
progesterone, hydrocrotisone and testosterone. Medium was renewed 3
times weekly. Seven days after the addition of hormones the average cell
number in three T-25 flasks in the different groups were determined.
found that the human breast cancer cell line T47D
can also be growth-inhibited by 15% NCS and that
this growth-inhibition can be abolished by
oestradiol (Lykkesfeldt, unpublished).
The growth curves presented in Figure 1 show
that oestradiol stimulation of MCF-7 cells grown
with 10% NCS results from an extension of the
logarithmic growth phase giving rise to a much
higher cell density in these cultures. This increase in
final cell number may be due to loss of density
inhibition. A similar oestradiol stimulation cannot
be achieved with MCF-7 cultures grown in low
NCS concentration (Lykkesfeldt & Briand, 1985).
However, cultures growing in low NCS concen-
trations proliferate rapidly and possess the ability
to grow to a high cell density, indicating that
growth inhibition may be a prerequisite for
oestradiol stimulation. Serum from athymic mice
contains a similar growth-inhibitory activity to that
found in NCS (Table I) and the need of MCF-7
cells for oestrogen to form tumours in athymic mice
may reflect the requirement for oestradiol
stimulation to attain the ability to grow without
density inhibition.
Stimulation of cell proliferation of MCF-7 cells
grown in 10% NCS can be obtained by addition ofOESTROGEN STIMULATION OF BREAST CANCER CELLS
Table III Oestrogen receptor content and effect of NCS and NCS+oestradiol on
human breast cancer cell lines
Cell number x 10i- +s.d.
Cell line Free ER'+s.d. 10% NCS 10% NCS+ 10-8M E2
HBL-100 <5 93.0+5.8 91.3+12.2
BT-20 <5 2.2+0.1 1.8+0.2
ZR-75-1 8+ 6 30.0+2.2 23.7+0.6
T47D 140+74 7.6+0.9 16.7+3.0
AL-1 123+26 5.9+0.8 5.8+0.4
MCF-7 213+ 5 12.8+3.7 76.8+3.5
afmolmg-' cytosol protein; Near confluent cultures grown for one week with
10% NCS were harvested and cytosols for oestrogen receptor determinations were
performed as described previously (Briand & Lykkesfeldt, 1984). The dextran-
charcoal technique was used for the oestrogen receptor (ER) determination
(EORTC Breast Cooperative Group, 1980). The number in the table is the average
of three receptor determinations +s.d. For the growth experiments, MCF-7, HBL-
100 and AL-1 cell lines were seeded with 0.5% FCS, and one day after plating
three culture flasks received 10% NCS, three culture flasks 10% NCS+10-8M
oestradiol. The BT-20, ZR-75-1 and T47D cell lines were maintained at 10% FCS
and have been adapted to growth at 10% NCS for a week before start of the
experiment to reduce the cellular oestrogen content supplied by the FCS. The cells
were plated in 10% NCS and one day after plating the cultures were divided into 2
groups, one group received 10% NCS another 10% NCS+ 10-8 M oestradiol.
Medium was renewed three times weekly, and cell number in three T-25 flasks
determined at day 7.
Table IV Progesterone receptor content in oestrogen
receptor positive human breast cancer cell lines grown
with 10% NCS or 10% NCS+10-8M oestradiol
Progesterone receptor
contenta +s.d.
Cell line 10% NCS 10% NCS+E2




afmolmg-' cytosol protein; Near confluent cultures
grown for one week with 10% NCS or 10% NCS+ 10-8M
oestradiol were harvested and cytosols prepared as
described previously (Briand & Lykkesfeldt, 1984). The
dextran charcoal technique was used for the progesterone
receptor determination (EORTC Breast Cooperative
Group, 1980). The number in the table is the average of
three receptor determinations+s.d.
oestradiol (10-8M, 10-10M) and a high
concentration of testosterone (10-8 M). This
stimulatory effect of high testosterone concentration
may be an oestradiol effect since MCF-7 cells can
convert testosterone to oestradiol (Maclndoe,
1978).
The results in Tables III and IV demonstrate that
only oestrogen receptor positive cell lines on which
oestradiol induces the synthesis of progesterone
receptor show an increase in cell number as the
response to the oestradiol addition. The ZR-75-1
cell line is usually hormone response (Darbre et al.,
1983), but our subline contains a very low amount
of oestrogen receptors indicating that this cell line
may have changed during the cultivation in our
laboratory. The AL-1 cell line is a tamoxifen
resistant subline derived from MCF-7 cells. Growth
in the presence of oestradiol does not induce
progesterone receptor synthesis in this subline
although the oestrogen receptors are determined as
filled receptors tightly associated with the
chromatin (unpublished observation). We assume
that the antioestrogen resistance of the AL-1 cell
line as well as the lack of oestrogen stimulation is
due to a defect oestrogen-receptor mechanism.
These experiments bring evidence for an indirect
mechanism of oestrogen stimulation involving the
abolition of inhibitory activity present in serum.
Only oestrogen receptor positive cell lines with a
functional oestrogen receptor mechanism are
growth promoted by oestradiol. However, a
functioning receptor mechanism leads only to
stimulation of cell proliferation in cells which are
growth inhibited since oestradiol added to MCF-7
cells grown in 0.5% FCS does not stimulate cell
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proliferation although progesterone receptor
synthesis is significantly increased (Briand &
Lykkesfeldt, 1984; Lykkesfeldt, unpublished).
The demonstration of inhibitory activity in
athymic mouse serum may indicate that oestradiol
also acts in vivo by abolishing inhibitory activity as
proposed earlier by Shafie (1980). As suggested by
Huseby et al. (1984) oestradiol may act directly on
the MCF-7 cells, and we assume that oestradiol via
the oestrogen receptor mechanism induces the
synthesis of a substance which abolishes the effect
of the inhibitory activity in serum.
Dell'Aquila et al. (1984) have purified a factor
from plasma-derived human serum that inhibits the
growth of the oestrogen receptor positive MCF-7
cells but not the oestrogen receptor negative HBL-
100 cells. Whether this purified inhibitory factor
from plasma derived human serum is similar to the
inhibitory activity we have described in the present
paper, and to the inhibitory activity which Soto
and Sonnenschein (1984) have found in human
female sera and foetal bovine sera remains to be
elucidated. It will be interesting to analyse human
sera from breast cancer patients for the presence or
absence of inhibitory activity and correlate the
results with oestrogen receptor status. If there is a
positive correlation between the presence of
inhibitor in the serum and oestrogen receptor
positive breast tumour, valuable new information
may be obtained about the biology of the
oestrogen-dependent breast tumour which may
bring new perspectives for the endocrine treatment
of breast cancer.
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